Verastem | VSTM - Debt


Verastem reported $66.79M in Debt for its fiscal quarter ending in September of 2024.





Debt Change Date
AbbVie USD 1000K 70.48B Sep/2025
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
AstraZeneca USD 32.63B 207M Sep/2025
Curis USD 0 0 Jun/2022
Cytokinetics USD 1.2B 338.79M Sep/2025
Gilead Sciences USD 24.94B 5M Sep/2025
Incyte USD 40.41M 855K Dec/2025
Laboratory Of America USD 6.53B 16.1M Sep/2025
Novartis USD 32.64B 1.37B Jun/2025
Pfizer USD 60.85B 78M Sep/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
TG Therapeutics USD 245.34M 8.38M Sep/2025
Verastem USD 66.79M 26.7M Sep/2024